| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/16/2009 | CN101530400A Effervescence tablet capable of treating penis erection dysfunction and preparation method thereof |
| 09/16/2009 | CN101530399A Silibinin solid self-emusifying tablet and preparation method thereof |
| 09/16/2009 | CN101530398A Tablet suitable for the administration of children and manufacturing method thereof |
| 09/16/2009 | CN101530397A Phloroglucinol freeze-dried powder injection composition for injection |
| 09/16/2009 | CN101530396A Method for preparing an amlodipine microsphere |
| 09/16/2009 | CN101530395A Method for preparing LTB-carboxymethyl chitosan influenza vaccine intranasal immunization microspheres |
| 09/16/2009 | CN101530394A Polypeptide-chitosan composite nanoparticles loaded with coenzyme Q10 and preparation method thereof |
| 09/16/2009 | CN101530393A Clindamycin phosphate lipidosome freeze-dried preparation and preparation method thereof |
| 09/16/2009 | CN101530392A Omeprazole sodium freeze-dried lipidosome preparation and preparation method thereof |
| 09/16/2009 | CN101530391A Creatine phosphate sodium lipidosome freeze-dried preparation and preparation method thereof |
| 09/16/2009 | CN101530390A Preparation of Alpha-linolenic acid nanoliposome preparation and prescription |
| 09/16/2009 | CN101530389A Ginsenoside Rg 3 and phospholipid complex and preparing method thereof |
| 09/16/2009 | CN101530388A Formulation of mildronate injection and preparation method |
| 09/16/2009 | CN101530387A An oral intake slowback pharmaceutic preparation |
| 09/16/2009 | CN101530386A Gel with the active component being 11-hydroxy-oleanane-28-carboxylic acid methyl ester-2,12-diene |
| 09/16/2009 | CN100540080C Method and apparatus for vaporizing a compound |
| 09/16/2009 | CN100540063C Articles comprising mint odor-free cooling agent |
| 09/16/2009 | CN100540059C Rotavirus gene vaccine based on NSP4 gene |
| 09/16/2009 | CN100540055C Biodegradable block copolymeric compositions for drug delivery |
| 09/16/2009 | CN100540048C Angiogenesis inducer |
| 09/16/2009 | CN100540028C Film coating agent fro treating wound, bone ache caused from wind dampness and preparing method |
| 09/16/2009 | CN100540016C Fat-reducing speckle-removing cosmetic mixture and its capsule |
| 09/16/2009 | CN100540008C Release delayed solid oral prophylactic or pregnancy stopping pill and its use |
| 09/16/2009 | CN100540007C Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof |
| 09/16/2009 | CN100540006C Platinum derivative pharmaceutical formulations |
| 09/16/2009 | CN100540004C Nasal pharmaceutical composition of piribedil |
| 09/16/2009 | CN100540000C Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal double infection and fungal recurrences |
| 09/16/2009 | CN100539997C Mitoxantrone or liposome of mitoxantrone hydrochloric acid, and preparation method |
| 09/16/2009 | CN100539879C Method of inhibiting water content variation of composition and use thereof |
| 09/16/2009 | CN100539862C Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same |
| 09/15/2009 | US7589238 Treatment of hyperphosphatemia using crosslinked small molecule amine polymers |
| 09/15/2009 | US7589237 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine |
| 09/15/2009 | US7589208 Solid dosage of a salt of a 3-quinoline-carboxamide derivative that is storage stable for three years; e.g. lithium or calcium salt of laquinimod |
| 09/15/2009 | US7589169 Carrier with a metal binding domain, a metal ion, and an active agent; e.g., polylysine with a polyoxyethylene side chain with a polyalkylenepolyaminepolyacetic acid bonded to a transition metal ion bonded to a protein or nucleotide; drug delivery |
| 09/15/2009 | US7589128 Process for preparation of amorphous form of a drug |
| 09/15/2009 | US7589084 Anticancer compositions, and methods of making and using the same |
| 09/15/2009 | US7589082 Making a slow release estradiol formulation by exposing particles of estradiol and cholesterol to a low relative humidity, then a solvent-saturated atmosphere of acetone and water, drying and recovering; avoids undesirable hormone imbalances; can be injected monthly; low estradiol dissolution rate (EDR) |
| 09/15/2009 | US7589080 β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases |
| 09/15/2009 | US7589072 carrier having guanidinium groups enhancing drug delivering across a biological membrane, nuclear membrane or blood-brain barrier into a cell; an ionic complex through ionic bonds between the carrier and the drug or diagnostic reagent |
| 09/15/2009 | US7589071 increasing hemaglobin production in a mammalian cell in vitro; introducing a heterologous polynucleotide using the vector into cell by culturing; treating HIV/AIDS viral infection |
| 09/15/2009 | US7589064 Formulations of ramipril |
| 09/15/2009 | US7588825 Embolic compositions |
| 09/15/2009 | US7588787 Medicated production for local use based on natural materials |
| 09/15/2009 | US7588786 Polyoxyl 35 castor oil; medium chain mono- and diglycerides, an essential oil, and a (poorly soluble) drug such as ubiquinone; capsules, solid dosage forms |
| 09/15/2009 | US7588782 Rare earth metal compositions for treating hyperphosphatemia and related methods |
| 09/15/2009 | US7588781 oral administering a mixture powders comprising a dissolved whey protein to increase release the bioactive carotenoid, polyphenol, vitamins, flavonoid, isoflavone, ceramide |
| 09/15/2009 | US7588780 Embolization |
| 09/15/2009 | US7588779 time-release dosage forms contains antihyperglycemic drug metformin and angiotensin antagonist selected from the group consisting of valsartan, losartan, candesartan, eprosartan, irbesartan, olmesartan, tasosartan, and telmisartan |
| 09/15/2009 | US7588778 Delivery carrier for targeting to cells expressed with somatostatin receptors |
| 09/15/2009 | US7588753 Synergistically pro-penetrating solutions for ungual/peri-ungual dermatological/cosmetic applications |
| 09/15/2009 | US7588752 Derived from milk protein casein; for use in dentistry |
| 09/15/2009 | US7588703 Microencapsulation system and method |
| 09/15/2009 | US7588564 Apparatus for piezoelectric layer-wise pump and valve for use in local administration of biological response modifiers and therapeutic agents |
| 09/15/2009 | US7588558 Laminated sprinkler hypodermic needle |
| 09/15/2009 | CA2473991C Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor |
| 09/15/2009 | CA2463583C Highly compressible ethylcellulose for tableting |
| 09/15/2009 | CA2459924C Process for preparing concentrate thickener compositions |
| 09/15/2009 | CA2451233C Stackable low depth tray |
| 09/15/2009 | CA2421683C Microparticles for delivery of the heterologous nucleic acids |
| 09/15/2009 | CA2415065C Oral compositions comprising host-response modulating agent |
| 09/15/2009 | CA2400155C A novel crystalline form of n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid and process therefor |
| 09/15/2009 | CA2393483C Stable pharmaceutical preparations comprising a benzimidazole and process for their production |
| 09/15/2009 | CA2371462C Modified protein matrices |
| 09/15/2009 | CA2330330C Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug |
| 09/15/2009 | CA2309100C Lovastatin compositions derived from red rice fermentation products, fermentation processes and monascus strains therefor |
| 09/15/2009 | CA2294086C Palatable elemental medical food |
| 09/15/2009 | CA2255052C Sustained release preparation of prostaglandin i derivatives |
| 09/15/2009 | CA2168203C Medicinal for protection from neurological damage |
| 09/11/2009 | WO2009111638A1 Compositions and methods for drug delivery |
| 09/11/2009 | WO2009111588A1 Immunomodulator particles and methods of treating |
| 09/11/2009 | WO2009111437A2 Monodispersed organic monolayer coated calcium-containing nanoparticles |
| 09/11/2009 | WO2009111418A2 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 09/11/2009 | WO2009111294A1 Topotecan ready to use solutions |
| 09/11/2009 | WO2009111221A1 Polyoxyalkylene siloxane copolymers with antistatic properties and their application to fiberglass insulation and other substrates |
| 09/11/2009 | WO2009111218A2 Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same |
| 09/11/2009 | WO2009111200A1 Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor |
| 09/11/2009 | WO2009111105A1 Controlled release drug delivery systems and pharmaceutical compositions formed therewith |
| 09/11/2009 | WO2009111088A2 Antitumor immunization by liposomal delivery of vaccine to the spleen |
| 09/11/2009 | WO2009111040A1 Hand sanitizing patch |
| 09/11/2009 | WO2009110954A1 Multiple reservoir implantable drug infusion device and method |
| 09/11/2009 | WO2009110862A1 Methods to inhibit tumor cell growth by using proton pump inhibitors |
| 09/11/2009 | WO2009110464A1 Composition for improvement in nutrition |
| 09/11/2009 | WO2009110351A1 Transdermally absorbable preparation |
| 09/11/2009 | WO2009110335A1 Chewing gum containing eucalyptus extract |
| 09/11/2009 | WO2009110041A1 Cancer therapeutic agent by agent for cancer-specific introduction of prostacyclin receptor antagonist |
| 09/11/2009 | WO2009110005A2 Modified release pharmaceutical compositions comprising mycophenolate and processes thereof |
| 09/11/2009 | WO2009110004A1 Stable pharmaceutical compositions qf carvedilol |
| 09/11/2009 | WO2009109993A1 Extended release dosage form of paliperidone |
| 09/11/2009 | WO2009109990A2 Pharmaceutical composition of pramipexole |
| 09/11/2009 | WO2009109966A1 Vaginal carrier for the controlled release of substances |
| 09/11/2009 | WO2009109900A1 Stimulation of ocular retrobulbar flow using ocular irritants |
| 09/11/2009 | WO2009109869A2 Alcohol antimicrobial skin sanitizing compositions including cationic compatible thickeners |
| 09/11/2009 | WO2009109741A1 Clopidogrel solution for oral administration |
| 09/11/2009 | WO2009109547A1 Pharmaceutical solutions, process of preparation and therapeutic uses |
| 09/11/2009 | WO2009109476A1 Process for preparing concentrated aqueous micellar solutions |
| 09/11/2009 | WO2009109390A1 Macrolide compositions having improved taste and stability |
| 09/11/2009 | WO2009109289A2 Mixture for producing rapidly disintegrating tablets |
| 09/11/2009 | WO2009109266A1 Improved isomalt-containing tablets and methods for the production thereof |
| 09/11/2009 | WO2009109214A1 Process for preparing a pharmaceutical composition with anti-inflammatory and analgesic activity for administration via a patch for external use, and composition thus obtained |
| 09/11/2009 | WO2009109109A1 Use of tea polyphenols in preparing medicaments for prevention or treatment of tumors |